SEC Form 4 · accession 0001683168-18-001779
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wright Don
Director
Period of report
Jun 21, 2018
Accepted (ET)
Jun 25, 2018 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $1.66 | Jun 21, 2018 | A | 8,655 | A | — | Jun 21, 2028 | Common Stock | 8,655 | 8,655 | D |
| Stock Options (Right to Buy)F2 | $1.66 | Jun 21, 2018 | A | 38,462 | A | — | Jun 21, 2028 | Common Stock | 38,462 | 38,462 | D |
| Stock Options (Right to Buy)F3 | $1.66 | Jun 21, 2018 | A | 30,000 | A | — | Jun 21, 2028 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant.
- F2Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 9/21/2018.
- F3Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) June 21, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control.